Non-Invasive Prenatal Testing (NIPT) Market Estimated To Flourish At USD 5.5 Billion By 2025 : Grand View Research Inc.
San Francisco, 21 August 2019: The Report Non-Invasive Prenatal Testing (NIPT) Market Size, Share & Trends Analysis Report, By Gestation Period (0-12 weeks, 13-24 weeks, 25-36 weeks), By Risk (High & Average Risk, Low Risk) And Segment Forecasts, 2018 – 2025 The global non-invasive prenatal testing market is anticipated to reach USD 5.5 billion by 2025, according to a new report by Grand View Research, Inc. Evolution of prenatal testing in the form of noninvasive tests that can serve as an intermediate step between serum screening and invasive diagnostic testing to determine the likelihood of fetal abnormality is expected to drive growth in the reproductive genetics industry over the forecast period. In addition, presence of payers such as Anthem and Blue Shield of California that have endorsed cfDNA-based Noninvasive Prenatal Testing (NIPT) for trisomies 13, 18, and 21 is expected to impact the adoption rate of these tests, thereby resulting in increased revenue gen